CABA Cabaletta Bio, Inc Year-over-year net earnings per share growth for the last 12 months
Cabaletta Bio, Inc. (CABA) is developing innovative cell therapy by attracting leading geneticists through its scientific culture and stock options. This chart on the GURU.Markets platform illustrates the percentage change in quarterly EPS, where the 35.00 metric determines this level. The company is currently spending its reserves on costly clinical trials, which is creating a cash deficit. The absence of regular sales and high R&D expenses preclude operational stability.
Analytical breakdowns and data insights for company Cabaletta Bio Inc (CABA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Cabaletta Bio, Inc.|CABA - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Cabaletta Bio, Inc.|CABA - Company Aggregate Debts|Debts to Book Capitalization Cabaletta Bio, Inc|CABA - Company Long-Term Debt|Company Short-Term Debts Cabaletta Bio, Inc.|Quick Liquidity cabalettabio.com
- earnings and market multiples details:
CABA - Company Net Income|Projected Future Earnings Cabaletta Bio, Inc.|CABA - Market Cap to Earnings|Projected Price to Earnings Cabaletta Bio, Inc|CABA - Company Value to Earnings Growth Ratio|Enterprise Value to EBITDA Ratio Cabaletta Bio, Inc|CABA - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Cabaletta Bio, Inc.|CABA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months cabalettabio.com|CABA - Earnings per share increase in current year|Earnings growth forecast for next year Cabaletta Bio, Inc.
Initial company analysis:Cabaletta Bio - CABA
A portfolio analyst utilizes this indicator to verify the credit quality and financial stability of the issuer. The growth potential of Cabaletta Bio (CABA) is supported by the innovative CARTA platform, which provides high-precision therapy for autoimmune pathologies. The quarterly EPS comparison reflects the daily price action of net income per share. The increase in this metric confirms the efficiency of the operating model and the fundamental strength of the balance sheet. This positive trend serves as a signal regarding the capitalization of the company's technological advantage.
Direct competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Celldex Corp (CLDX) - Year-over-year net earnings per share growth for the last 12 months|AUPH: Quarterly EPS earnings growth|biocryst.com (BCRX) - Quarterly EPS earnings growth|VERA (Vera Therapeutics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months DNTH|Quarterly EPS earnings growth PHVS|Quarterly EPS earnings growth AbCellera Bio (ABCL)|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|precigen.com - Year-over-year earnings per share growth for the last twelve months|Pharming Group - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Year-over-year net earnings per share growth for the last 12 months|ZBIO: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months IMNM|GOSS (gossamerbio.com) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth KALV|Quarterly EPS earnings growth Septerna, Inc. (SEPN)|Pieris Pharmaceuticals Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SVRA|Rigel Pharmaceuticals - Quarterly EPS earnings growth|ANAB: Year-over-year earnings per share growth for the last twelve months|ATXS: Quarterly EPS earnings growth|ENGN - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months RAPT Therapeutics|Earnings per share growth in annualized terms for the last twelve months Aerovate JBIO|Year-over-year net earnings per share growth for the last 12 months ACRS (Aclaris Therapeutics)|KYTX (kyvernatx.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences Ltd)|Year-over-year net earnings per share change for the last twelve months Ventyx Biosciences Inc. (VTYX)|THTX - Year-over-year earnings per share growth for the last twelve months|AVTX (Avalo Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|ELDN: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months agenusbio.com|Year-over-year net earnings per share growth for the last 12 months CLYM|zurabio.com (ZURA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ATYR|Year-over-year net earnings per share growth for the last 12 months adagene.com ADAG|Quarterly EPS earnings growth IMA (Ikena Oncology)|Quarterly EPS earnings growth Shattuck Labs Inc STTK|Equillium Bio - Quarterly EPS earnings growth|CNTB: Year-over-year earnings per share growth for the last twelve months|IMUX: Quarterly EPS earnings growth|Atara Bio (ATRA) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months InflaRx NV|x4pharma.com - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ACET|CELU (celularity.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth INMB (INmune Bio Corp)|Quarterly EPS earnings growth Barinthus Biotherapeutics Corp BRNS|KZR - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months SABS (sabbiotherapeutics.com)|Akari Therapeutics Plc (AKTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Enlivex Therapeutics Ltd.|QTTB (Q32 Bio Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth GeoVax Corp|Year-over-year net earnings per share growth for the last 12 months EDSA (Edesa Biotech, Inc.)|IBIO (ibioinc.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc.)|Year-over-year net earnings per share change for the last twelve months XTL Biopharmaceuticals Ltd (XTLB)|BOLT - Year-over-year earnings per share growth for the last twelve months|HCW Biologics Inc. (HCWB) - Year-over-year net earnings per share growth for the last 12 months|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|Year-over-year net earnings per share growth for the last 12 months ADTX|Quarterly EPS earnings growth GRI Bio Inc|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Vyome Therapeutics - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth REVB (Revelation Biosciences)|indaptusrx.com (INDP) - Earnings per share growth in annualized terms for the last twelve months|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|CalciMedica, Inc. (CALI) - Year-over-year net earnings per share growth for the last 12 months|AFMD: Quarterly EPS earnings growth|Allakos (ALLK) - Quarterly EPS earnings growth|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months IGMS|Quarterly EPS earnings growth ITOS|Quarterly EPS earnings growth Ocean Biomedical Inc (OCEA)|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|Third Harmonic Bio Inc - Year-over-year earnings per share growth for the last twelve months
